nach oben

Reactions Weekly

Erschienen in:

01.06.2017 | Case report

Metreleptin

Development of antibodies: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

In a case series, a 16-year-old girl was described, who developed antibodies during treatment with metreleptin. The girl, who had a history of acquired generalised lipodystrophy, started receiving treatment with SC 0.02 mg/kg metreleptin injection twice daily for one month. Later, the dose was increased to 0.04 mg/kg. Subsequently, she developed antibodies to metreleptin [duration of treatment to reaction onset and outcome not stated]. …

Lebastchi J, et al. A report of three cases with acquired generalized lipodystrophy with distinct autoimmune conditions treated with metreleptin. Journal of Clinical Endocrinology and Metabolism 100: 3967-3970, No. 11, 2015. Available from: URL: http://doi.org/10.1210/jc.2015-2589 - USA

Titel: Metreleptin
Development of antibodies: case report
Publikationsdatum: 01.06.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-31652-5

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Metreleptin

Development of antibodies: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Alemtuzumab

Capecitabine

FBTA-05/mycophenolate-mofetil

Metformin/sitagliptin

Lercanidipine

Sevelamer